You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

August 9, 2022

Vietnam Issues New Guidance on Medical Device Regulations

In late 2021, the government of Vietnam issued Decree 98 on the management of medical devices (Decree No. 98/2021/ND-CP dated November 8, 2021), which came into force on January 1, 2022. This is the primary legislation on medical devices in Vietnam. To provide necessary guidance and elaboration on the implementation of Decree 98, the Ministry of Health recently issued Circular No. 05/2022/TT/BYT dated August 1, 2022 (“Circular 05”), which took effect on the same day.

The most notable aspect of Circular 05 is that it unifies, in a single legislative document, previous regulations on medical devices that were scattered in multiple circulars issued by the Ministry of Health (Circular No. 39/2016/TT-BYT dated October 28, 2106; Circular No. 46/2017/TT-BYT dated December 15, 2017, as amended by Circular No. 23/2021/TT-BYT dated December 9, 2021; and Circular No. 33/2020/TT-BYT dated December 31, 2020). The effectiveness of these circulars was terminated when Circular 05 took effect.

Circular 05 sets out regulations and principles for the classification of medical devices, and adds or supplements the following lists:

  1. List of in vitro diagnostic medical devices (IVD) not subject to quality assessment by Vietnamese competent authorities when registering under the quick registration procedure.
  2. List of class B, C and D medical devices allowed to be traded as normal goods.
  3. List of medical devices required to be accredited for safety and technical functions before use.
  4. List of medical devices requiring import permit licenses.

While Circular 05 does not introduce major changes to the previous regulations, the consolidation and up-to-date guidance on Decree 98 will simplify the task of registration and circulation for medical device companies doing business in Vietnam.

RELATED INSIGHTS​ 

September 19, 2019
The August 2019 edition of Global Regulatory Press’ Journal of Medical Device Regulation  features a Vietnam overview authored by two of Tilleke & Gibbins’ regulatory affair specialists in the jurisdiction—Hien Thi Thu Vu, head of the regulatory affairs team in Vietnam, and Mai Thi Le, regulatory affairs consultant in Vietnam.
September 19, 2019
Dr. Atthachai Homhuan, manager of regulatory affairs at Tilleke & Gibbins, recently contributed the Thailand overview for the May 2019 edition of Global Regulatory Press’ Journal of Medical Device Regulation —an industry-specific journal that provides an insider’s perspective into the regulatory world surrounding medical devices in jurisdictions around the world.In the Thailand overview, Dr. Atthachai covers the following topics:
September 5, 2019
On Friday August 30, 2019, a Notification of the Thai Ministry of Public Health (“MOPH Notification”) was published in the Government Gazette. The MOPH Notification went into effect on August 31, 2019, one day after its publication.This MOPH Notification outlines another Thai Government initiative in connection with the free cannabis policy, this time carving out further aspects of marijuana and hemp use from the stringent regulations under the Narcotics Act.
September 4, 2019
The 2019 edition of Thomson Reuters’ Practical Law Life Sciences Global Guide  has been released, with its Pharmaceutical Intellectual Property and Competition Law in Cambodia chapter written by practitioners from Tilleke & Gibbins’ Phnom Penh office.The guide is a Q&A-style overview of the regulatory frameworks for the life sciences industries across jurisdictions worldwide. This chapter on pharmaceutical IP and competition law in Cambodia addresses the following issues in the country’s legal landscape for life sciences: